Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence D True

Showing results (121-130 of 204) with videos related to

Pageof 21
Sort By:
Prostate Cancer and Prostatic Diseases|August 30, 2019
The development and comparative effectiveness of a patient-centered prostate biopsy report: a prospective, randomized studyJasmir G Nayak, Nicholas Scalzo, Alice Chu, et al.
The Journal of Urology|June 18, 2011
The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance: a multi-institutional studyJesse K McKenney, Jeff Simko, Michael Bonham, et al.
Cancer Research|September 24, 2009
Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancerIlona N Holcomb, Janet M Young, Ilsa M Coleman, et al.
Cancer Research|May 19, 2007
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancerElahe A Mostaghel, Stephanie T Page, Daniel W Lin, et al.
The Prostate|February 4, 2017
LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating Cancer TherapeuticsHolly M Nguyen, Robert L Vessella, Colm Morrissey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2024
Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer BiopsiesMichael C Haffner, Michael J Morris, Chien-Kuang C Ding, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 20, 2023
Visual Assessment of 2-Dimensional Levels Within 3-Dimensional Pathology Data Sets of Prostate Needle Biopsies Reveals Substantial Spatial HeterogeneityCan Koyuncu, Andrew Janowczyk, Xavier Farre, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 22, 2010
CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarkerLawrence D True, Hui Zhang, Mingliang Ye, et al.
Epigenetics|September 28, 2011
A DNA methylation microarray-based study identifies ERG as a gene commonly methylated in prostate cancerJacob Schwartzman, Solange Mongoue-Tchokote, Angela Gibbs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2013
Targeted androgen pathway suppression in localized prostate cancer: a pilot studyElahe A Mostaghel, Peter S Nelson, Paul Lange, et al.
Pageof 21

Showing results (121-130 of 204) with videos related to

Sort By:
Pageof 21
Prostate Cancer and Prostatic Diseases|August 30, 2019
The development and comparative effectiveness of a patient-centered prostate biopsy report: a prospective, randomized studyJasmir G Nayak, Nicholas Scalzo, Alice Chu, et al.
The Journal of Urology|June 18, 2011
The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance: a multi-institutional studyJesse K McKenney, Jeff Simko, Michael Bonham, et al.
Cancer Research|September 24, 2009
Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancerIlona N Holcomb, Janet M Young, Ilsa M Coleman, et al.
Cancer Research|May 19, 2007
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancerElahe A Mostaghel, Stephanie T Page, Daniel W Lin, et al.
The Prostate|February 4, 2017
LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating Cancer TherapeuticsHolly M Nguyen, Robert L Vessella, Colm Morrissey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2024
Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer BiopsiesMichael C Haffner, Michael J Morris, Chien-Kuang C Ding, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 20, 2023
Visual Assessment of 2-Dimensional Levels Within 3-Dimensional Pathology Data Sets of Prostate Needle Biopsies Reveals Substantial Spatial HeterogeneityCan Koyuncu, Andrew Janowczyk, Xavier Farre, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 22, 2010
CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarkerLawrence D True, Hui Zhang, Mingliang Ye, et al.
Epigenetics|September 28, 2011
A DNA methylation microarray-based study identifies ERG as a gene commonly methylated in prostate cancerJacob Schwartzman, Solange Mongoue-Tchokote, Angela Gibbs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2013
Targeted androgen pathway suppression in localized prostate cancer: a pilot studyElahe A Mostaghel, Peter S Nelson, Paul Lange, et al.
Pageof 21